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E-mail address: ernest.giralt@irbbarcelona.org (E.Prolyl oligopeptidase (POP) has gained importance as a target for the treatment of neuropsychiatric
diseases and cognitive disturbances. Therefore, a variety of strategies are currently used to identify
POP inhibitors. Here we performed electron microscopy (EM) studies of human POP. Our data reveal
for the ﬁrst time the presence of a new side opening in POP that was not observed in any of the crys-
tallographic structures described to date. Finally, molecular dynamics, the relevant normal modes
that contribute to the ﬂuctuation of the catalytic triad residues and the algorithm CAVERN also sup-
port the existence of a new large side opening on POP.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Prolyl oligopeptidase (POP; EC 3.4.21.26) is a cytosolic serine
protease that hydrolyses small proline-containing peptides [1]. In
recent years this protease has been associated with the metabo-
lism of inositol-1,4,5-P3 (IP3), a key molecule in the transduction
cascade of neuropeptide signaling [2–4]. Given the neuroprotective
and cognition-enhancing effects of POP inhibitors in experimental
animals [5–8], these compounds might be valuable for the treat-
ment of a variety of clinical conditions of the brain, such as the cog-
nitive disturbances present in neurodegenerative diseases. In
addition, POP inhibitor S-17092-1 has been tested in Phase I clini-
cal trials for its capacity to enhance cognition [9,10]. Hence, given
the promising therapeutic effects of POP inhibitors, an array of
strategies is currently being used to identify these compounds
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Giralt).The X-ray structure of POP from porcine muscle revealed a dis-
tinctive two-domain structure: a catalytic domain with an a/b
hydrolase fold, and an unusual b-propeller domain [15,16]. The
catalytic domain resembles canonical serine proteases such as
trypsin and chymotrypsin, whereas the unique propeller domain
forms a tight barrel-shaped lid over the active site. The structure
of POP suggests that this propeller domain contributes to limiting
substrate accessibility. It was proposed that the oscillating propel-
ler blades act as a gating ﬁlter during catalysis, thereby allowing
access only to the active site of small peptide substrates [17]. Later,
Szeltner et al. [18] reported that the apparently rigid crystal struc-
ture of POP does not explain how the substrate approaches the cat-
alytic groups. By engineering disulﬁde bridges between the blades
1 and 7 of the propeller and between the peptidase and the propel-
ler domain, these authors showed that the oscillating movements
that would lead to catalytic activity could be prevented, thereby
resulting in inactive enzyme forms. It was then suggested that con-
certed movements of the propeller and the peptidase domains are
essential for the action of the enzyme.
However, by expression of the propeller domain as a soluble
protein, it was shown that the unclosed propeller was a stable
structure. Hence, it was proposed that the opening between the
peptidase and the propeller domains is the substrate entry path-
way [19]. This hypothesis was conﬁrmed by molecular dynamicslsevier B.V. All rights reserved.
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rigidity of the propeller domain, which would not permit the sub-
strate to approach the active site. Nevertheless, a smaller tunnel in
the inter-domain region comprising the highly ﬂexible N-terminal
segment of the peptidase domain was identiﬁed as the only poten-
tial pathway for the substrate [20].
Despite the enormous amount of data available on POP, impor-
tant questions remain, including protein ﬂexibility and substrate
access to and product egress from the active site. Here, we present
the ﬁrst report of electron microscopy (EM) studies of human POP.
2. Materials and methods
2.1. Expression and puriﬁcation of human POP
POP was obtained by expression in Escherichia coli and afﬁnity
puriﬁcation using a His tail fusion following a previously described
procedure [21].
2.2. Native electrophoresis
Non-denaturing or native electrophoresis was performed as de-
scribed previously [22] using a POP antibody raised against porcine
POP (Fig. S2).
2.3. Electron microscopy and image processing
For electron microscopy, 5-l aliquots of POP in 50 mM TrisHCl,
pH 8 (0.2 mg/ml), either in the absence or the presence of the
H(Ahx)2Arg(Ahx)3ProProH inhibitor (10 equiv. dissolved in Aceto-
nitrile:H2O, the acetonitrile concentration in the EM sample was
0.5%), were applied to glow-discharged carbon grids for 1 min
and then stained for 1 min with 2% non-buffered uranyl acetate.
The staining agent was subsequently blotted and the grids were
left to dry before being observed at the electron microscope.
Images were recorded at 0 tilt in a JEOL 1200EX-II electron micro-
scope operated at 100 kV and recorded on Kodak SO-163 ﬁlm at
60 000 nominal magniﬁcation.
Micrographs were digitized in a Zeiss SCAI scanner with a sam-
pling window corresponding to 3.5 Å/pixel. Particles (4564) of POP
and 6532 particles of the inhibitor-treated POP were extracted
from the micrographs using XMIPP software [23]. For the three-
dimensional reconstruction of both POP and the inhibitor-treated
POP, three different strategies (noise, a Gaussian blob and the
atomic structure of porcine POP (1UOP.pdb) ﬁltered at very low
resolution (60 Å)), were independently used to generate a starting
model, which in the three cases rendered similar results. Projec-
tions from all the template volumes were confronted to the data
set using angular reﬁnement methods implemented in EMAN
[24] until, after several iterations, the volume remained stable.
By Fourier Shell Correlation (eotest command in EMAN), the reso-
lution of the ﬁnal structure of the POP and inhibitor-bound POP
was estimated to be 21 and 22 Å (using the 0.3 cross-correlation
coefﬁcient criteria).
Visualization of the three-dimensional reconstructions and
docking of the atomic structure of POP (1qfm.pdb) into the two
three-dimensional reconstructions was performed using UCSF
Chimera [25].
2.4. Molecular dynamics simulations
MD calculations at two temperatures (300 K and 400 K) were
carried out to explore the conformational ﬂexibility of POP. The
program NAMD [26] with the CHARMM force ﬁeld [27] were used
in all simulations. The homology model of human POP [28] or the
atomic structure of POP (1qfm.pdb) was prepared with VMD [29]using the psfgen utility of NAMD. The solvate script of VMD was
used to construct a simulation box of 88  95  110 Å3 containing
24.886 water molecules around the protein. In order to generate
electrostatically neutral simulation cells, 22 water molecules were
replaced with sodium atoms. First, the energy of the system was
minimized with ﬁxed positions for all heavy atoms. MD calcula-
tions were performed at constant temperature and volume. The
temperature was maintained at 300 K or 400 K using weakly cou-
pled Langevin dynamics of non-hydrogen atoms with damping
coefﬁcient of 10 ps1. Bonds to all hydrogen atoms were kept rigid
using SHAKE [30], permitting a time step of 1.8 fs. The system was
simulated in periodic boundary conditions, with a cut-off of non-
bonded and electrostatic interactions at 11 Å and switching be-
tween 10 and 11 Å was used. The total simulation length for all
systems was 8 ns. Rmsd values of protein structure with respect
to the X-ray structure were computed to evaluate the ﬂexibility
of the POP protein.
3. Results and discussion
Aliquots of POP were negatively-stained as described in Section
2 and subjected to electron microscopy (EM). When observed at
the electron microscope, the preparation looked reasonably homo-
geneous, with a large proportion of what looked to be end-on
views (arrows in the Supplementary Fig. S3) and side views
(arrowheads). Despite its small size (710 residues, catalytic domain
residues 1–72 and 428–710, b-propeller residues 73–427), a three-
dimensional (3D) reconstruction was generated as explained in
Section 2 (Fig. S4). Albeit with a much lower resolution, this recon-
struction resembled the X-ray structure of this enzyme (Fig. 1, yel-
low), including a small opening at the bottom of the b-propeller
domain (Fig. 1C). However, the 3D reconstruction revealed also
the presence of a large aperture (Fig. 1B) that was not observed
in any of the crystallographic structures described so far [15,16].
This new opening was much larger than the one observed by X-
ray diffraction in the centre of the b-propeller domain (Fig. 1C),
and was localized between the catalytic and the b-propeller do-
mains. An additional small opening was also observed at the inter-
face of the two domains (Fig. 1A), which could be attributed to the
‘‘breathing” between the two.
Afterwards, we performed a second 3D reconstruction to
observe the enzyme structure when interacting with a ligand. En-
zyme particles were incubated with a covalent inhibitor derived
from the canonical POP inhibitor Z-L-prolyl-L-prolinal (ZPP) [31],
H(Ahx)2Arg(Ahx)3ProProH (IC50 = 1.4 nM, Fig. S1) (Fig. 2B). The
rationale behind the use of this inhibitor was that, being larger
than ZPP, it would cause an effect similar to the native peptide
substrates. The 3D reconstruction of the inhibitor-treated parti-
cles (Fig. 1, blue) revealed that the large aperture was not affected
by the presence of inhibitor (Fig. 1B, blue) while the small open-
ing at the bottom of the b-propeller domain was not visible
(Fig. 1C, blue). These results suggest a conformational change of
the protein when interacting with the inhibitor or an occlusion
of the hole.
Then, to visualize POP in the free estate and when interacting
with an inhibitor native electrophoresis was performed [22]. Sur-
prisingly, several bands were detected when recombinant POP
was loaded in a native gel whereas the sample migrated as a single
band when resolved by denaturing electrophoresis (Fig. 2A). The
absence of oligomeric forms was conﬁrmed by gel ﬁltration chro-
matography (Supplementary data Fig. S5). Moreover, the plot of
the Rf of the main bands versus the percentage of acrylamide/bis-
acrylamide of the gel showed parallel lines for bands 3 and 2
(Fig. 2A), suggesting that bands 3 and 2 could be attributed to dif-
ferent POP conformations. The same experiment carried out after a
previous incubation of POP with ZPP showed that only one band
Fig. 1. (A–C) Three views of the three-dimensional reconstructions of human POP (yellow) and POP in the presence of the inhibitor H(Ahx)2Arg(Ahx)3ProProH (blue). The
transparent view shows the docking of the atomic structure of porcine POP (1uop.pdb) into the three-dimensional reconstruction of human POP.
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Fig. 2. (A) Top, native electrophoresis of recombinant human POP resolved at four concentrations of acrylamide/bisacrylamide (%T: 7.5%, 10%, 12.5%, 15%). On the right, the
same POP sample resolved on an SDS–PAGE is shown. Bottom, plot of the Rf of the three main bands versus the percentage of acrylamide/bisacrylamide (%T). (B) Native
electrophoresis (10%) of recombinant human POP previously incubated with several covalent inhibitors. A control with DMSO (solvent to dilute the inhibitors) was
performed. The structures of the inhibitors tested are shown on the right. (C) Immunoblot of a native electrophoresis (10%) containing recombinant human POP (right) and
human brain tissue (left) performed using an in-house polyclonal antibody raised against porcine POP. The pH of the separating gels of both native gels and SDS–PAGE was
the same, pH 8.8 (TrisHCl). No salts were added. The pI of POP is 5.5.
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might modify POP conformation (Fig. 2B). Furthermore, other
covalent POP inhibitors, III-2-B, III-8-B and the same inhibitor used
for EM (H(Ahx)2Arg(Ahx)3ProProH), produced the same effects as
ZPP (Fig. 2B). The same main two bands as those observed with re-combinant POP were detected in human brain extract (Fig. 2C),
thereby showing that distinct POP conformations could also be
present in native samples.
The large side opening of POP identiﬁed in this study does not
coincide with the area of highest mobility predicted by the MD
Fig. 4. The two most probable accessible paths (in white) from the active centre of
POP (in ribbon representation) to solvent as identiﬁed by CAVER [33].
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performed an 8-ns MD simulation with our homology model of
human POP [28] which showed that, at this time scale, the en-
zyme is practically rigid and no new openings occur. To explore
slow conformational changes that could occur in a time scale that
cannot be studied with room temperature MD calculations, we
performed MD calculations at high temperature (400 K), starting
from the crystal conformation of POP. In this kind of simulation,
the most ﬂexible regions of POP were identiﬁed (Fig. 3). The core
of the two domains appeared to be rigid, and there was mobile
region situated between them. It is worth noting that the most
ﬂexible region found by previous MD [20] was also detected in
our 400 K calculations. However, our results indicate that the
ﬂexible region of POP extended to a broader area situated be-
tween the two domains (Fig. 3). In addition, we used a tool of
the AD-ENM server [32] to identify the relevant normal modes
that contribute signiﬁcantly to the ﬂuctuation of the catalytic
triad residues of the POP active site. Similar results to those by
400 K MD calculations were obtained (Supplementary data
Fig. S6). The dynamically relevant residues that correlate with
the ﬂuctuation of POP triad residues were located in an area that
comprises the region predicted by Fuxreiter et al. [20] and the
new region observed by EM. Finally, by using the recently de-
scribed algorithm CAVER [33], which allows recognition of pro-
tein cavities, we identiﬁed two paths leading from the POP
active site to the outside solvent. One of these paths coincided
with the new large side opening identiﬁed by EM in this study
(Fig. 4, top cavity) and the other with that already described by
X-ray through the b-propeller domain (Fig. 4, bottom cavity)
and also found by EM.
A substrate/inhibitor entrance route through the b-propeller
could explain the occlusion of the hole observed by EM after addi-
tion of the inhibitor. However, this route was previously reported
to be improbable [18,20]. Moreover, the shorter route though theFig. 3. Ribbon representation of the crystal structure of POP indicating the most
ﬂexible regions obtained by molecular dynamic calculations. In the color scale,
green is used for more rigid and blue for more ﬂexible regions.side opening appears to provide an easier and kinetically favored
access to and egress from the active site. Our results are also con-
sistent with previous studies in which an opening between the two
domains was proposed as the potential substrate entry pathway
for POPs [19,34]. Thus, our data provide the ﬁrst experimental evi-
dence of the presence of a new putative substrate/inhibitor en-
trance/exit route in mammalian POPs that might be relevant for
the design of a new generation of POP inhibitors with enhanced
pharmacological properties. Moreover, our results may show that
the conformation of the enzyme can differ depending on its activ-
ity state. These ﬁndings are consistent with data reported previ-
ously by Szeltner et al. [18].
In conclusion, here we present the ﬁrst report of a large side
aperture on POP detected by EM and that was not observed in
any of the crystallographic structures described to date. Our results
provide a highly attractive starting point to perform further exper-
iments to clarify the entrance and egress of substrates and prod-
ucts in POP and to study its putative conformational plasticity.
These questions, once clariﬁed, will be crucial for the design of
new POP inhibitors with diverse mechanisms of action.
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